Genetic
To determine the presence of biallelic expansion of AAGGG in RFC1 in patients with chronic cough, regardless of the presence of neurological symptoms.
To determine the presence of biallelic expansion of AAGGG in RFC1 in patients with chronic cough, regardless of the presence of neurological symptoms. is a genetic therapy with 1 clinical trials. Historical success rate of 100.0%.
Total Trials
1
Max Phase
—
Type
GENETIC
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
1
all time
Status Distribution
Completed(1)
Detailed Status
Completed1
Development Timeline
Analytics
Development Status
Total Trials
1
Active
0
Success Rate
100.0%
Trials by Status
completed1100%
Recent Activity
Clinical Trials (1)
Showing 1 of 1 trials
All 1 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 1